-
When anti-corruption in the medical industry is underway, supervision focuses on pharmaceutical companies' sales expenses
Anti-corruption in the medical industry is one of the goals of the new round of medical reform. This time, the anti-corruption campaign has been carried out in many ways.
2019-07-14
-
363 drugs suspended online! Many large varieties have been questioned and complained.
Guangxi Zhuang Autonomous Region Public Resources Trading Center Pharmaceuticals and Medical Devices Centralized Purchasing Office issued the "Notice on Requesting Price Clarification of Questioned and Complained Products" (hereinafter referred to as the "Notice"), and suspended the online trading qualifications of questioned and complained products.
2019-06-20
-
Negotiations for inclusion of 17 anti-cancer drugs in the National Medical Insurance Catalogue reduced prices by an average of 56.7%
Recently, the National Health Commission held a press conference to introduce the progress of the comprehensive reform of public hospitals in 2018.
2019-06-17
-
Medical staff in more than 2,800 public hospitals have to raise their salaries. Will seeing a doctor become expensive?
Recently, the General Office of the State Council issued the key tasks for deepening the reform of the medical and health system in 2019, including the dynamic adjustment of medical service prices in accordance with the principle of “total control, structural adjustment, rising and falling, and gradual implementation”.
2019-06-16
-
The State Food and Drug Administration issued a document, the opportunity for the development of Chinese medicine is here!
Opportunities for the development of Chinese medicine have come. As we all know, Chinese medicine has been criticized by the industry in terms of clinical research, and many Chinese patent medicines are simply linked with the concept of adjuvant medicine.
2019-06-01
-
Qinghai Province follows up "4+7", medical insurance prepayment starts in June
Qinghai's "Plan" stated that it adopts a negotiated procurement method that is in line with the bidding companies. Each type of medicine is shortlisted and one is selected. The procurement volume shall not be less than 80% of the actual use volume of drugs in 2018, which shall be reported to the planned procurement volume for allocation.
2019-05-30
- Company Overview
- News
- Core Business
- Product Center
- Marketing Network
- Talents Wanted
- Contact Us
- Friendly Link： Guangzhou Zesheng Pharmaceutical Technology Co., Ltd
- Address：Address：35/F, Tower 3, Dongjun Plaza, No.836 Dongfeng East Road, Guangzhou
- Sales Department I：020-87620372
- Sales Department II：020-87675002
- Fax：020-87305940
Contact number for International business: Tel.: 020-37674724 Mobile: 15920406316 Email: iris@zeshengpharma.com
-
Applets
-
Pay attention to the public number